Topiramate
- Product NDC
- 43063-998
- 11-digit product format
- 430630998
- Labeler code
- 43063
- Product ID
- 43063-998_3a22cbea-53cc-4e02-e063-6294a90aef45
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Topiramate
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Application
- ANDA090278
- Marketing category
- ANDA
- Marketing start
- 2014-12-15
- Substance
- TOPIRAMATE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A090278-001 | TOPIRAMATE | TOPIRAMATE | 25MG | TABLET / ORAL | AB | 2009-03-27 | |
| A090278-002 | TOPIRAMATE | TOPIRAMATE | 50MG | TABLET / ORAL | AB | 2009-03-27 | |
| A090278-003 | TOPIRAMATE | TOPIRAMATE | 100MG | TABLET / ORAL | AB | 2009-03-27 | |
| A090278-004 | TOPIRAMATE | TOPIRAMATE | 200MG | TABLET / ORAL | 2009-03-27 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A090278-001 | AB |
| A090278-002 | AB |
| A090278-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A090278-001 | TOPIRAMATE | 25MG | TABLET / ORAL | AB | 2009-03-27 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A090278-002 | TOPIRAMATE | 50MG | TABLET / ORAL | AB | 2009-03-27 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A090278-003 | TOPIRAMATE | 100MG | TABLET / ORAL | AB | 2009-03-27 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A090278-004 | TOPIRAMATE | 200MG | TABLET / ORAL | 2009-03-27 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A090278-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A090278-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A090278-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Topiramate | TOPIRAMATE | PD-Rx Pharmaceuticals, Inc. | e846124d-e9e6-42c7-83f1-5df170d3f70b | 2026-07-07 | Warnings, Adverse reactions | 090278 ANDA090278 |
| Topiramate | TOPIRAMATE | Bryant Ranch Prepack | 47ef2964-3a41-4bfd-86fb-d44560b9961f | 2026-06-24 | Warnings, Adverse reactions | 090278 ANDA090278 |
| Topiramate | TOPIRAMATE | Bryant Ranch Prepack | 484c132f-3d3d-4218-b22f-82e9b56cc2f4 | 2026-06-24 | Warnings, Adverse reactions | 090278 ANDA090278 |
| Topiramate | TOPIRAMATE | PD-Rx Pharmaceuticals, Inc. | 1b847969-2124-4350-94b0-ef5ba707673b | 2026-06-08 | Warnings, Adverse reactions | 090278 ANDA090278 |
| Topiramate | TOPIRAMATE | PD-Rx Pharmaceuticals, Inc. | 021005ab-6a00-40d8-9aee-20c91613b4d5 | 2026-06-08 | Warnings, Adverse reactions | 090278 ANDA090278 43063-998 |
| Topiramate | TOPIRAMATE | Sun Pharmaceutical Industries, Inc. | 3c909a53-ae66-4b28-a741-b60bb25a69cf | 2026-06-01 | Warnings, Adverse reactions | 090278 ANDA090278 |
| Topiramate | TOPIRAMATE | Bryant Ranch Prepack | 61390be3-7553-4cb5-b5da-7571ed7d4b17 | 2024-08-20 | Warnings, Adverse reactions | 090278 ANDA090278 |
| Topiramate | TOPIRAMATE | Bryant Ranch Prepack | ffaacad8-4594-45a8-b292-02a84cd0c35b | 2024-08-20 | Warnings, Adverse reactions | 090278 ANDA090278 |
| Topiramate | TOPIRAMATE | NuCare Pharmaceuticals,Inc. | 9ddb8451-a455-87ec-e053-2995a90a5e5e | 2024-06-20 | Warnings, Adverse reactions | 090278 ANDA090278 |
| Topiramate | TOPIRAMATE | Proficient Rx LP | 8bd03bb2-3b9b-4707-a9a4-5618ddc3832f | 2023-07-01 | Warnings, Adverse reactions | 090278 ANDA090278 |
| TOPIRAMATE | TOPIRAMATE | Proficient Rx LP | a30c583a-4b0a-43a6-ae76-19b1a5e916ca | 2022-10-01 | Warnings, Adverse reactions | 090278 ANDA090278 |
| Topiramate | TOPIRAMATE | Proficient Rx LP | e382a731-ef73-4990-bc74-ffc3a91ff3ba | 2022-06-01 | Warnings, Adverse reactions | 090278 ANDA090278 |
| Topiramate | TOPIRAMATE | Proficient Rx LP | 7d6752ce-7a56-4b04-ab15-cbd40aa5cc94 | 2019-11-01 | Warnings, Adverse reactions | 090278 ANDA090278 |
| Topiramate | TOPIRAMATE | Sun Pharmaceutical Industries, Inc. | 2d9513e0-2fb8-46c9-bbd6-b03efd31c3ef | 2018-11-01 | Warnings, Adverse reactions | 090278 ANDA090278 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Topiramate
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| TOPIRAMATE | 25 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 0H73WJJ391 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 199888 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 021005ab-6a00-40d8-9aee-20c91613b4d5 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| e5b1b0ba-27f8-4d5d-8943-8aed080fdedc | Product name | 4 | 20260306 |
| 6c26dd6d-01b5-4a80-b096-b3a6f7ca6077 | Product name | 2 | 20250623 |
| cb966f54-bbf0-40fb-b581-80c6648d510c | Product name | 4 | 20250623 |
| 6e2fb0d7-40d7-e97c-1375-fa022ff20193 | Product name | 4 | 20250305 |
| 3d272a3f-17c0-421d-bc43-3cbdb719258d | Product name | 1 | 20250303 |
| 594e2c86-3079-4e6e-96c9-48f7a8afc78d | Product name | 1 | 20230718 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 43063-998-30 | Topiramate | 30 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 30 | 21 | |
| 43063-998-60 | Topiramate | 60 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 60 | 21 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 43063-998-30 | EA - Each | 43063-998 | c5d9e7fb-62a8-496a-8026-9920588d86d9 | 1 | 2019-09-05 |
| 43063-998-60 | EA - Each | 43063-998 | 5a77b49b-9932-4c26-aeb6-8bc6810d40af | 1 | 2019-09-05 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 199888 | topiramate 25 MG Oral Tablet | PSN | 021005ab-6a00-40d8-9aee-20c91613b4d5 | 21 |
| 199888 | topiramate 25 MG Oral Tablet | SCD | 021005ab-6a00-40d8-9aee-20c91613b4d5 | 21 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 43063-998-30 | 43063099830 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-998-30) | 2019-08-08 | 0000-00-00 | No | No | Current |
| 43063-998-60 | 43063099860 | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-998-60) | 2019-07-30 | 0000-00-00 | No | No | Current |